ACHIEVEMENTS THROUGH THE ESTABLISHMENT OF THE PCI
INDIVIDUAL SPECIAL INTERESTS OF PCI PERSONNEL
 |
Dr Paul de Souza: the role of clinical trial research in the development and discovery of more effective anti-cancer drugs to combat prostate cancer. |
 |
|
Dr Terry Diamond: endocrine assessment of men for osteoporosis following drug treatment for prostate cancer. |
|
|
Dr Bill Lynch: a new treatment for local prostate cancer: cryotherapy (freezing of the prostate gland). |
|
|
Dr Paul Cozzi: a new surgical technique for prostate cancer reduces the risk of side effects. |
|
|
Dr Joe Bucci: I-125 seed brachytherapy and HDR brachytherapy for early stage prostate cancer. |
|
|
Dr Joe Bucci: high dose-rate brachytherapy for prostate cancer. |
|
|
Kim Small/Professor Kearsley: installation of multileaf collimators to improve efficacy of external beam radiotherapy for prostate cancer. |
|
|
Dr Raymond Clarke: It’s all in the genes - discovering the genetic basis for prostate cancer in families. |
|
|
Professor Barry Allen: a novel new approach to improving prostate cancer treatment - targeted alpha therapy. |
|
|
Professor Anatoly Rozenfeld: real time physics dosimetry improves the accuracy of brachytherapy for prostate cancer patients. |
|
|
Jacqueline Lim and social workers: exploring the role of support groups for men with prostate cancer. |
|
|
